Bogus 'Conversion Therapy' Leads to Higher Risk of Mental Illness for LGBT People
By Ernie Mundell HealthDay Reporter
TUESDAY, Oct. 1, 2024 -- Besides being useless in altering a person's sexuality or gender identity, so-called "conversion therapy" or "conversion practice" can greatly raise the odds that an LGBT person experiences mental health issues, new research finds.
Questionnaires completed by over 4,400 LGBTQ+ Americans found that having undergone these bogus interventions was linked to higher rates of depression, post-traumatic stress disorder (PTSD) and suicidal thoughts or attempts.
“Our findings add to a body of evidence that shows conversion practice is unethical and linked with poor mental health," said study lead author Dr. Nguyen Tran, of Stanford University School of Medicine.
"Protecting LGBTQ+ people from the impacts of these harmful practices will require multi-pronged legislation, including state and federal bans," Tran added. "Additional measures such as support networks and targeted mental health support for survivors are also vital."
The findings were published Sept. 30 in The Lancet Psychiatry journal.
Conversion therapy is any kind of formal, structured effort to alter a person's sexuality or gender identification, often employing psychological, behavioral, physical and faith-based practices.
Most respected professional medical and mental health organizations are opposed to the practice, although it's still offered at sites throughout the United States.
Anywhere from 4% to 34% of LGBTQ+ American children and adults may have been subjected to conversion practices, according to a Lancet news release.
The data used in the new study came from the ongoing PRIDE study, which has been tracking the health of LGBTQ+ people across America. About 57% identified as cisgender and 43% identified as transgender. Ages ranged from 18 to 34, with the average age being 31.
In total, 149 (3.4%) of those questioned had experienced conversion therapy focused on altering their sexual orientation, 43 (1%) had undergone practices targeting gender identity, and 42 (1%) reported both, the researchers reported.
Risk factors for having undergone conversion practices included having a religious upbringing and/or being brought up in a community that didn't support issues around gender identity, being from a minority group and having a lower level of education.
Conversion therapy aimed at changing a person's sexual orientation was most often delivered by a religious leader or group (52% of the time) or a mental health provider or organization (29%). Similar trends were seen for conversion practices aimed at gender identity.
"The highest levels of anxiety, depressive and PTSD symptoms were reported by participants who recalled conversion practice for gender identity alone," the researchers said.
However, folks who'd undergone conversion practices for both their sexuality and gender identity had the highest levels of suicidality, the team reported.
Conversion practices are definitely not in the mainstream of medical practice, said Dr. Jack Drescher, a clinical professor of psychiatry at Columbia University Medical Center, in New York City.
Writing in an accompanying commentary, he said that "mainstream mental health organizations need to do a better job of regulating the activities of those outlier, licensed clinicians who engage in conversion practices."
Drescher added that, "professional organizations’ ethical guidelines should mirror and integrate the wider world’s changing cultural beliefs and values regarding the growing acceptance of diverse sexual orientations and gender identities.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-02 00:00
Read more
- Celiac Disease Linked to Higher Risk for Developing Alopecia Areata
- Supreme Court Won't Hear Big Tobacco's Challenge to Cigarette Warning Labels
- Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study
- High Acceptance Seen for Liver Stiffness Test With Routine Retina Scan in T2DM
- Bribing Kids With Holiday Gifts Popular With Parents, Poll Says
- Scientists Develop Whole New Form of Effective Asthma Treatment
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions